10577 Results

Congress Abstract

Can deformable registration of CT and CBCT predict plan adaptation need in proton therapy (H&N)?

Authors:

Joanna Gora1, Angelica De Leon2, Gabriele Kragl3, Antonio Carlino2, Markus Stock2

1MedAustron Ion Therapy Center, Medical Department, Wiener Neustadt, Austria; 2MedAustron Ion Therapy Center, Medical Department , Wiener Neustadt, Austria; 3Ordensklinikum Linz GmbH Barmherzige Schwestern, Strahlentherapie, Linz, Austria

Show Affiliations

Journal Article

Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC)

Authors: Kerstin A. Kessel, Marco M.E. Vogel, Carmen Kessel, Henning Bier, Tilo Biedermann, Helmut Friess, Peter Herschbach, Rüdiger von Eisenhart-Rothe, Bernhard Meyer, Marion Kiechle, Ulrich Keller, Christian Peschel, Florian Bassermann, Roland Schmid, Markus Schwaiger, Stephanie E. Combs

Journal Article

The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapy

Authors: Eric Tran, Matthew Paquette, Justin Jay, Jeremy Hamm, Mitchell Liu, Graeme Duncan, Tom Pickles, Scott Tyldesley

Congress Abstract

Can SABR for painful bone metastases ever be cost-effective in the NHS?

Authors: Spencer|, Katie(1)*[katie.spencer1@nhs.net];Bojke|, Chris(1);Henry|, Ann(2);Velikova|, Galina(2);Morris|, Eva(3);van der Linden|, Yvette(4);van den Hout|, Wilbert(5);Hall|, Peter(6);
(1)University of Leeds, Leeds Institute of Health Sciences, Leeds, United Kingdom;(2)University of Leeds, Leeds Institute of Medical Research, Leeds, United Kingdom;(3)University of Leeds, Leeds Institute of Data Analytics, Leeds, United Kingdom;(4)Leiden University Medical Centre, Radiotherapy department, Leiden, The Netherlands;(5)Leiden University Medical Centre, Health Economics, Leiden, The Netherlands;(6)Edinburgh University, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom;
Show Affiliations

Congress Abstract

Outcome of proton therapy for salivary gland cancer and NTCP risk analysis for xerostomia/dysphagia

Authors:

Nicolas Bachmann1, Marc Walser1, Carson Tully1, Andreas Köthe1, Dominic Leiser1, Nicola Bizzocchi1, Damien Charles Weber1,2,3

1Paul Scherrer Institute, Center for Proton Therapy, Villigen, Switzerland; 2Inselspital, University Hospital Bern, Radiation Oncology, Bern, Switzerland; 3University Hospital of Zürich, Radiation Oncology, Zürich, Switzerland

Show Affiliations

Journal Article

Impact of electronic patient-reported outcome measures on patients’ perception of the physician - the randomized ePREFERENCE study

Authors: C. Gani, P. Bickenbach, A. Tenev, M. Niyazi, T. Festl-Wietek, A. Herrmann-Werner

Congress Abstract

Dose integration method of intensity-modulated arc therapy and HDR brachytherapy of prostate cancer

Authors: Fröhlich|, Georgina(1)*[turul49@yahoo.com];Ágoston|, Péter(1);Jorgo|, Kliton(1);Polgár|, Csaba(1);Major|, Tibor(1);
(1)National Institute of Oncology, Centre of Radiotherapy, Budapest, Hungary;
Show Affiliations

Journal Article

Modification of the microstructure of the CERN- CLEAR-VHEE beam at the picosecond scale modifies ZFE morphogenesis but has no impact on hydrogen peroxide production

Authors: Houda Kacem, Louis Kunz, Pierre Korysko, Jonathan Ollivier, Pelagia Tsoutsou, Adrien Martinotti, Vilde Rieker, Joseph Bateman, Wilfrid Farabolini, Gérard Baldacchino, Billy W. Loo, Charles L. Limoli, Manjit Dosanjh, Roberto Corsini, Marie-Catherine Vozenin

Journal Article

Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients

Authors: Wouter Schaake, Arjen van der Schaaf, Lisanne V. van Dijk, Alfons H.H. Bongaerts, Alfons C.M. van den Bergh, Johannes A. Langendijk
*:*